JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M Turnover 14.14%
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
+14.31%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$645M
AUM Growth
+$162M
Cap. Flow
+$96.4M
Cap. Flow %
14.95%
Top 10 Hldgs %
32.1%
Holding
158
New
30
Increased
45
Reduced
52
Closed
6
Avg Time Held
2.7 years
Top 10 Avg Time Held
3 years
Top 20 Avg Time Held
3 years

Sector Composition

Rank Sector Weight
1 Healthcare 26.21%
2 Technology 23.49%
3 Industrials 19.39%
4 Utilities 14.67%
5 Communication Services 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
EMR icon
1
Emerson Electric
EMR
$89.9B
$33.9M 5.25%
421,439
-6,708
-2% -$499K
2013 Q2
30 quarters
BMY icon
2
Bristol-Myers Squibb
BMY
$121B
$25M 3.87%
402,321
-5,328
-1% -$328K
2013 Q2
30 quarters
GLW icon
3
Corning
GLW
$121B
$22.9M 3.55%
635,327
-17,768
-3% -$631K
2013 Q2
30 quarters
PFE icon
4
Pfizer
PFE
$166B
$22.4M 3.47%
607,311
+28,321
+5% +$1.04M
2013 Q2
30 quarters
INTC icon
5
Intel
INTC
$519B
$19.3M 2.99%
387,616
+87,540
+29% +$4.28M
2013 Q2
30 quarters
T icon
6
AT&T
T
$158B
$18.4M 2.85%
846,619
+248,250
+41% +$5.35M
2017 Q2
14 quarters
OGE icon
7
OGE Energy
OGE
$9.81B
$17.5M 2.71%
548,213
+114,742
+26% +$3.71M
2013 Q2
30 quarters
MDU icon
8
MDU Resources
MDU
$3.9B
$16.2M 2.51%
1,614,055
+70,612
+5% +$660K
2013 Q2
30 quarters
NVS icon
9
Novartis
NVS
$279B
$16.1M 2.49%
170,433
+18,948
+13% +$1.66M
2013 Q2
30 quarters
XOM icon
10
ExxonMobil
XOM
$728B
$15.6M 2.42%
377,992
+216,875
+135% +$8.13M
2013 Q2
30 quarters
GSK icon
11
GSK
GSK
$95.9B
$15.1M 2.34%
327,773
+1,399
+0.4% +$64.3K
2013 Q2
30 quarters
IBM icon
12
IBM
IBM
$215B
$14.8M 2.3%
123,263
+27,193
+28% +$3.14M
2013 Q2
30 quarters
BCE icon
13
BCE
BCE
$18.3B
$14.6M 2.27%
342,068
+62,808
+22% +$2.69M
2013 Q2
30 quarters
JNJ icon
14
Johnson & Johnson
JNJ
$612B
$14.3M 2.22%
91,029
-754
-0.8% -$111K
2013 Q2
30 quarters
FLS icon
15
Flowserve
FLS
$8.92B
$14.2M 2.21%
386,131
+178,325
+86% +$5.84M
2016 Q2
18 quarters
XRAY icon
16
Dentsply Sirona
XRAY
$1.68B
$14.1M 2.18%
268,508
-1,975
-0.7% -$97.4K
2018 Q3
9 quarters
CSCO icon
17
Cisco
CSCO
$448B
$13.8M 2.14%
308,467
+54,133
+21% +$2.22M
2013 Q2
30 quarters
AGX icon
18
Argan
AGX
$5.13B
$13.8M 2.14%
309,566
+74,283
+32% +$3.33M
2018 Q2
10 quarters
MMM icon
19
3M
MMM
$84.8B
$13.5M 2.09%
92,090
-717
-0.8% -$102K
2013 Q2
30 quarters
LGTY
20
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$12.4M 1.92%
721,053
-6,280
-0.9% -$100K
2013 Q2
30 quarters
LNN icon
21
Lindsay Corp
LNN
$1.14B
$11M 1.71%
85,791
-633
-0.7% -$72.2K
2013 Q2
30 quarters
TSM icon
22
TSMC
TSM
$2.23T
$9.93M 1.54%
91,069
-2,150
-2% -$204K
2016 Q4
16 quarters
D icon
23
Dominion Energy
D
$55.2B
$9.66M 1.5%
128,444
+87,074
+210% +$6.92M
2020 Q3
1 quarter
TEL icon
24
TE Connectivity
TEL
$60.9B
$9.65M 1.5%
79,684
-583
-0.7% -$64.3K
2013 Q2
30 quarters
NJR icon
25
New Jersey Resources
NJR
$5.26B
$9.14M 1.42%
+257,165
New +$8.37M
2020 Q4
0 quarters

Similar funds

John G. Ullman & Associates's Q4 2020 Portfolio in Review

As of Q4 2020, John G. Ullman & Associates held 158 positions worth $645M, up 34% from $483M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

John G. Ullman & Associates deployed $96.4M of net new capital in Q4 2020, opening 30 new positions and adding to 45 existing holdings. Its largest new stake was New Jersey Resources: 257,165 shares worth $9.14M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, down from 32% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Albemarle, an estimated $1.84M trimmed.

  • John G. Ullman & Associates's largest Q4 2020 buy was New Jersey Resources: 257,165 shares worth $9.14M.
  • John G. Ullman & Associates added most to ExxonMobil in Q4 2020, an estimated $8.13M increase.
  • John G. Ullman & Associates's biggest Q4 2020 reduction was Albemarle, cutting an estimated $1.84M.
  • John G. Ullman & Associates fully exited Archer Daniels Midland in Q4 2020, selling an estimated $7.14M.
  • John G. Ullman & Associates's ten largest holdings make up 32% of its $645M portfolio in Q4 2020.
  • John G. Ullman & Associates opened 30 new positions and closed 6 in Q4 2020.
  • John G. Ullman & Associates's portfolio value rose 34% quarter-over-quarter to $645M.

Based on John G. Ullman & Associates's 13F filing for Q4 2020, filed 5 Feb 2021.